Please assess the completion status of the following clinical trial:

Trial Title: Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* previous poor response to ovarian stimulation in IVF.~Exclusion Criteria:~* patients over the age of 42~* patients who received DHEA at any time.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 42 Years
- Healthy Volunteers: f

Study Arms:
- DHEA supplementation (Type: EXPERIMENTAL): DHEA was added to induction of ovulation by recombinant FSH and recombinant LH, in IVF long protocol
- only induction of ovulation by same long protocol without DHEA (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).